Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Reduced risk of mortality found for losartan in ELITE study

March 19, 1997

Cardioprotective effects of KBR-9032

March 19, 1997

Alternative to bypass surgery presented at ACC meeting

March 19, 1997

Dual TNF/PDE IV inhibitors from SKB

March 19, 1997

Therapeutic potential of PAF antagonists in cardiac diseases

March 18, 1997

BMS-186716 associated with potent, long-lasting NEP/ACE inhibition in humans

March 18, 1997

Human pharmacokinetics and metabolism of clevidipine

March 18, 1997

Pharmacokinetics and hemodynamic effects of hBNP in CHF

March 18, 1997

Antiatherosclerotic compounds described by Fuji Photo Film

March 18, 1997

Potent, nonselective adenosine agonist from Schering-Plough

March 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...